Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Int J Pharm. 2021 Jan 22;596:120206. doi: 10.1016/j.ijpharm.2021.120206

Table 3.

Distance between blank nanoparticles (NP) and testing samples (lopinavir (LPV) and ritonavir (RTV) NP and solutions and Kaletra® tablet) based on the e-tongue measurement analyzed by “Masking Efficiency” (n = 6).

Sample Reference Distances (mean ± SD)

RTV NP Blank NP 9.37 ± 1.05
RTV solution Blank NP 18.31 ± 5.19
LPV NP Blank NP 8.48 ± 3.34
LPV solution Blank NP 22.61 ± 4.10
Kaletra® Blank NP 28.52 ± 5.69